Stocks TelegraphStocks Telegraph
Stock Ideas

CRDL Financial Statements and Analysis

NASDAQ : CRDL

Cardiol Therapeutics

$1.06
00
At Close 4:00 PM
53.78
B-ESG ScoreESG Rating

FINANCIAL STATEMENTS

An instrumental part of fundamental analysis is measuring key indicators of an asset, which are the factors that can influence its value and price. However, sometimes investors show more interest in financial statements with other factors to determine whether investing in that company is the right decision. Financial statements of a company include:

  • Balance Sheet
  • Income Statement
  • Cash Flow Statement

Income Statement

A company's income statement helps investors and business owners determine whether the company is profitable or losing money. Profitability is a key factor investors consider before investing in a stock. Income statements provide them with information about a company's profitability over time. The statement also enables them to observe trends in company spending and earnings since it breaks down individual costs and revenues. Income statements also provide details on where a company's money is going when it isn't profitable or its profits fluctuate.

DateMar 31, 2026Sep 30, 2025Jun 30, 2025Mar 31, 2025Sep 30, 2024
reported currencyCADCADCADCADCAD
calendar year20262025202520252024
periodQ1Q3Q2Q1Q3
revenue00000
cost of revenue26.709K025.47K24.986K0
gross profit-26.709K0-25.47K-24.986K0
gross profit ratio00000
research and development expenses4.949M4.787M2.732M3.757M3.751M
general and administrative expenses4.731M5.368M4.919M4.647M10.39M
selling and marketing expenses00000
selling general and administrative expenses4.731M5.368M4.919M4.647M10.39M
other expenses025.551K25.47K24.986K0
operating expenses9.68M10.18M7.676M8.429M14.14M
cost and expenses9.707M10.18M7.676M8.429M14.14M
interest income200.724K122.256K180.667K248.269K201.864K
interest expense00000
depreciation and amortization26.709K25.551K25.47K24.986K201.09K
ebitda-9.68M-9.939M-7.651M-8.404M-13.939M
ebitda ratio00000
operating income-9.707M-10.18M-7.676M-8.429M-14.14M
operating income ratio00000
total other income expenses net-1.112M215.819K-678.213K141.41K1.412M
income before tax-10.819M-9.964M-8.354M-8.288M-12.728M
income before tax ratio00000
income tax expense00000
net income-10.819M-9.964M-8.354M-8.288M-12.728M
net income ratio00000
eps-0.099-0.12-0.10-0.100
eps diluted-0.099-0.12-0.10-0.100
weighted average shs out108.988M84.727M82.653M82.609M0
weighted average shs out dil108.988M84.727M82.653M82.609M0
Graph

Balance Sheet

Balance sheet summarizes a company's financials and can be used as a basis by investors to determine the value of a company. It shows the value of the stock, as well as the assets and liabilities of the company. A company's balance sheet displays how its assets are put to use and how those assets are financed, based on the liabilities section. Both investors and analysts analyze a company's balance sheet to determine how it allocates its resources.

DateMar 31, 2026Sep 30, 2025Jun 30, 2025Mar 31, 2025Sep 30, 2024
reported currencyCADCADCADCADCAD
calendar year20262025202520252024
periodQ1Q3Q2Q1Q3
cash and cash equivalents27.673M11.622M18.195M23.293M15.885M
short term investments00000
cash and short term investments27.673M11.622M18.195M23.293M15.885M
net receivables339.706K195.88K279.887K346.69K266.706K
inventory00000
other current assets3.255M988.532K1.299M1.633M1.13M
total current assets31.268M12.807M19.774M25.272M17.282M
property plant equipment net138.969K140.981K163.514K182.545K237.926K
goodwill00000
intangible assets00000
goodwill and intangible assets00000
long term investments00000
tax assets00000
other non current assets00000
total non current assets138.968K140.981K163.514K182.545K237.926K
other assets00000
total assets31.407M12.948M19.938M25.455M17.52M
account payables0007.716M0
short term debt39.792K36.925K71.112K68.504K31.785K
tax payables00000
deferred revenue00000
other current liabilities7.087M3.253M7.952M-34.252K6.922M
total current liabilities7.127M3.29M8.023M7.751M6.954M
long term debt76.616K97.274K106.998K116.408K134.199K
deferred revenue non current00000
deferred tax liabilities non current00000
other non current liabilities00000
total non current liabilities76.615K97.274K106.998K116.408K134.199K
other liabilities00000
capital lease obligations116.408K134.199K142.554K150.66K165.984K
total liabilities7.203M3.387M8.13M7.867M7.088M
preferred stock00000
common stock212.802M187.363M179.539M179.335M154.631M
retained earnings-223.892M-205.904M-195.896M-187.542M-171.70M
accumulated other comprehensive income loss2.82M0000
other total stockholders equity32.472M28.103M28.165M25.794M27.50M
total stockholders equity24.203M9.561M11.808M17.588M10.431M
total equity24.203M9.561M11.808M17.588M10.431M
total liabilities and stockholders equity31.407M12.948M19.938M25.455M17.52M
minority interest00000
total investments00000
total debt116.408K134.199K142.554K150.66K165.984K
net debt-27.557M-11.488M-18.052M-23.142M-15.719M
Graph

Cash Flow

A cash flow statement is regarded as a valuable indicator of profitability and the long-term outlook for a company. It assists the company in evaluating whether it has sufficient funds to cover its expenses. Essentially, a cash flow statement represents an organization's financial health. The cash flow statement, which measures the business's ability to operate in the short as well as long term, is broken down into operating, investing, and financing activities.

DateMar 31, 2026Sep 30, 2025Jun 30, 2025Mar 31, 2025Jun 30, 2024
reported currencyCADCADCADCADCAD
calendar year20262025202520252024
periodQ1Q3Q2Q1Q2
deferred income tax00000
stock based compensation1.843M4.00M2.54M1.147M1.806M
change in working capital119.107K-622.146K671.355K-151.824K782.038K
accounts receivables-113.511K84.007K66.803K14.931K74.682K
inventory00000
accounts payables1.628M0270.839K739.695K578.264K
other working capital-1.396M-706.153K333.713K-906.45K129.092K
other non cash items1.312M-363.74K566.79K113.75K442.094K
net cash provided by operating activities-7.518M-6.925M-4.551M-7.154M-4.776M
investments in property plant and equipment-47.585K-3.018K-6.439K-11.939K-3.80K
acquisitions net00000
purchases of investments00000
sales maturities of investments00000
other investing activites00000
net cash used for investing activites-47.585K-3.018K-6.439K-11.939K-3.80K
debt repayment-13.844K-13.844K-13.844K-13.844K-9.229K
common stock issued13.614M034.26K087.313K
common stock repurchased00000
dividends paid00000
other financing activites000087.00
net cash used provided by financing activities13.60M-13.844K20.416K-13.844K78.084K
effect of forex changes on cash221.941K369.229K-561.052K-107.778K149.681K
net change in cash6.257M-6.573M-5.098M-7.287M-4.552M
cash at end of period27.673M11.622M18.195M23.293M24.021M
cash at beginning of period21.417M18.195M23.293M30.58M28.573M
operating cashflow-7.518M-6.925M-4.551M-7.154M-4.776M
capital expenditure-47.589K-3.018K-6.439K-11.939K-3.80K
free cash flow-7.565M-6.928M-4.557M-7.166M-4.78M
Graph

Frequently Asked Questions

How did Cardiol Therapeutics Inc. do last quarter? What was its Total Revenue and Cost of Revenue?
A company's Total Revenue reveals how much money it generates before any expenses or deductions are made. As a result, this metric informs investors/stakeholders how much money the business makes. Tracking and understanding it is essential for evaluating a company's growth. As opposed to revenue, Cost of Revenue is any expenses a business incur to generate revenue. There can be high revenue in a business, but if the costs are high, it won't make a profit and will go out of business when money runs out. Therefore, CRDL generated $0.00 in revenue last quarter, while its costs came in at $26.71K.
Last quarter, how much Gross Profit did Cardiol Therapeutics Inc. report?
A business's Gross Profit is a key indicator of its profitability and financial performance. In other words, it reflects how efficiently a business uses labor, raw materials, and other resources. Cardiol Therapeutics Inc. reported a -$26.71K Gross Profit for the quarter ended Mar 31, 2026.
Have CRDL's Total Operating Expenses and Operating Income been favorable recently?
Operational Expenses represent the costs a company must incur to generate revenue, which is the ultimate goal of a business, whereas Operating Income shows the revenue left after operational direct and indirect costs have been deducted. CRDL incurred $9.68M worth of Operating Expenses, while it generated -$9.71M worth of Operating Income.
How much Net Income has CRDL posted recently?
The Net Income of a company is one of the factors investors consider when investing in the company. According to recent earnings report from Cardiol Therapeutics Inc., the company generated -$10.82M in Net Income. When a company has a history of consistent net income, investors are more likely to invest in it since they know they will get a return.
At the end of the last quarter, how much Cash and Equivalents did Cardiol Therapeutics Inc. have?
The amount of Cash and Cash Equivalents is an effective indicator of the financial strength and well-being of a company. An excess cash situation occurs when a company has more cash and cash equivalents than it needs for operating activities. The amount of Cash and Cash Equivalents available to Cardiol Therapeutics Inc. as of the end of the last quarter was $27.67M.
What are CRDL's Total Net Receivables for the last quarter?
Total Net Receivables are a company's outstanding debts to its customers. Therefore, it refers to the amount that a company expects to collect from its customers. The higher a company's net receivables are, the more confident it is that it can collect money from its debtors. As of the end of the last quarter, CRDL had Total Net Receivables of $339.71K.
In terms of Total Assets and Current Assets, where did Cardiol Therapeutics Inc. stand at?
An asset with an economic value within a year is considered a current asset. Total assets, however, also include long-term fixed assets, intangible assets, and other non-current assets. The current Assets of CRDL were $31.27M, while the Total Assets stand at $31.41M.
As of the last quarter, how much Total Debt did Cardiol Therapeutics Inc. have?
The total debt of a business refers to how much it borrows. A company's current and long-term liabilities are added together to calculate its Total Debt. A debt ratio may be taken into account on a balance sheet by financial lenders, investors, and business leaders when making informed decisions about future loans or investments. The total amount of CRDL's debt was $116.41K at the end of the last quarter.
What were CRDL's Total Liabilities during the last reported quarter?
A company's total liabilities are the sum of all debts it is liable for, including any off-balance shee liabilities it may incur. This can be calculated by adding up all short-term and long-term liabilities. In its last quarter, CRDL reported total liabilities of $7.20M.
How much did CRDL's Working Capital change over the last quarter?
Working Capital Change for CRDL was $119.11K over the last quarter. Working Capital Change refers to the difference between net working capital amounts at the end of one accounting period and the end of another. It tells investors/stakeholders how much the company's cash flow will differ from its Net Income (i.e., after-tax profits). More powerful companies often have positive Change in Working Capital numbers as they have increased control over collecting cash from customers and delaying payments to suppliers.
CRDL generated how much cash from operating activities?
An operating cash flow statement usually contains cash from operating activities in the first section. An organization's cash from operating activities refers to the money it takes in and takes out as a result of its regular business operations. CRDL generated -$7.52M of Cash from Operating Activities during its recently reported quarter.
What was CRDL's latest reported Net Change in Cash?
An increase or decrease in cash and cash equivalent balances within a specified period is considered the net change in cash in a cash flow statement. Furthermore, it takes into account cash changes as a result of investments, financing, and operating activities. CRDL reported a $6.26M Net Change in Cash in the most recent quarter.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph